Diferencia entre revisiones de «Carbapenems»
(Text replacement - "==Source==" to "==References== <references/>") |
|||
| (No se muestran 3 ediciones intermedias de 3 usuarios) | |||
| Línea 4: | Línea 4: | ||
#[[Imipenem]] | #[[Imipenem]] | ||
#[[Meropenem]] | #[[Meropenem]] | ||
#[[Meropenem-vaborbactam]]<br /> | |||
==Indications== | ==Indications== | ||
* Cephalosporin-resistant nosocomial bacteria | *Cephalosporin-resistant nosocomial bacteria | ||
* Empirical treatment of serious infections in patients who recently received other | *Empirical treatment of serious infections in patients who recently received other beta-lactams | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Revisión actual - 05:14 4 ene 2022
Types
Indications
- Cephalosporin-resistant nosocomial bacteria
- Empirical treatment of serious infections in patients who recently received other beta-lactams
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
References
Goodman & Gilman's Pharmacology